Cargando…
Comparative effectiveness of medical treatments /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Science,
[2009]
|
| Colección: | Health care issues, costs, and access.
Novinka (Series) |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Comparative Effectiveness in Other CountriesOPTIONS FOR ORGANIZING AND FUNDING FEDERAL RESEARCH EFFORTS; ISSUES AND CHALLENGES IN COMPARING THE EFFECTIVENESS OF TREATMENTS; Methods of Research; Scope of Analysis and Dissemination of Results; POTENTIAL IMPLICATIONS FOR HEALTH CARE SPENDING; Potential for Savings on Health Care; Possible Responses Under Private and Public Insurance Plans; CONCLUSION; REFERENCES; Chapter 2: PRODUCING COMPARATIVE-EFFECTIVENESS INFORMATION; CONTEXT FOR MEDICARE PAYMENT POLICY; DEFINING COMPARATIVE EFFECTIVENESS.
- The Private Sector Does Not Systematically Produce and Disseminate Objective Comparative-Effectiveness InformationConducting Comparative-Effectiveness Studies Is Not the PrimaryFocus of Any Federal Agency; The United States Needs to Produce More Credible Comparative-Effectiveness Information; Comparative Information Could Help Payers Make Better Policies; More Comparative Information Could Help Support BetterDecision Making by Patients and Providers; Functions and Activities of a Comparative-Effectiveness Entity; Structuring an Entity to Examine and Report on ComparativeEffectiveness.
- CONCLUSIONChapter 3: TESTIMONY OF STEVEN M. TEUTSCH, M.D., M.P.H. EXECUTIVE DIRECTOR, OUTCOMES RESEARCH, EXTERNAL MEDICAL AND SCIENTIFIC AFFAIRS, MERCK & CO., INC. BEFORE THE HOUSE WAYS AND MEANS, HEALTH SUBCOMMITTEE CONCERNING COMPARATIVE EFFECTIVENESS JUNE 12, 2007; MERCK AND COMPARATIVE EFFECTIVENESS; NECESSARY CHARACTERISTICS OF THE NATIONAL COMPARATIVE EFFECTIVENESS EFFORT; STAKEHOLDER CONCERNS; CONCLUSION; SELECTED PUBLICATIONS RELEVANT TO COMPARATIVE EFFECTIVENESS.
- Chapter 4: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF CAROLYN M. CLANCY, M.D., DIRECTOR, AGENCY FOR HEALTHCARE RESEARCH AND QUALITY, ROCKVILLE, MARYLAND TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007EFFECTIVE HEALTH CARE PROGRAM; COMPARATIVE EFFECTIVENESS REVIEWS; Gastroesophageal Reflux Disease (GERD); Breast Cancer Diagnosis; Managing Anemia in Cancer Patients; Osteoarthritis Drugs; Renal Artery Stenosis; Off-Label Use of Atypical Antipsychotics; Second-Generation Antidepressants; Health Information Technology; CONCLUSION.